Lifecore Biomedical, Inc. (FRA:LDE)
Germany flag Germany · Delayed Price · Currency is EUR
6.55
+0.20 (3.15%)
At close: Dec 5, 2025

Lifecore Biomedical Ratios and Metrics

Millions EUR. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 May '25 May '24 May '23 May '22 May '21 2020 - 2016
Market Capitalization
246220158225272288
Upgrade
Market Cap Growth
-0.42%38.80%-29.68%-17.19%-5.72%2.86%
Upgrade
Enterprise Value
388370281369396464
Upgrade
Last Close Price
6.555.805.157.658.909.25
Upgrade
PE Ratio
--14.29---
Upgrade
PS Ratio
2.161.931.342.332.623.48
Upgrade
PB Ratio
5.875.253.196.863.311.73
Upgrade
P/TBV Ratio
----4.172.45
Upgrade
P/OCF Ratio
--667.99--21.32
Upgrade
EV/Sales Ratio
3.513.252.373.823.815.61
Upgrade
EV/EBITDA Ratio
--397.55-29.8269.55
Upgrade
EV/EBIT Ratio
-----192.89
Upgrade
EV/FCF Ratio
-32.32-----
Upgrade
Debt / Equity Ratio
2.762.762.393.211.711.07
Upgrade
Debt / EBITDA Ratio
--101.44-9.6321.03
Upgrade
Asset Turnover
0.520.520.510.390.290.19
Upgrade
Inventory Turnover
2.452.452.141.961.460.96
Upgrade
Quick Ratio
1.461.461.021.230.220.42
Upgrade
Current Ratio
2.842.842.092.390.661.46
Upgrade
Return on Equity (ROE)
-76.41%-76.41%20.97%-104.52%-10.65%-10.80%
Upgrade
Return on Assets (ROA)
-3.04%-3.04%-1.77%-4.67%-0.55%0.35%
Upgrade
Return on Capital (ROIC)
-4.16%-4.16%-2.72%-6.39%-0.65%0.42%
Upgrade
Return on Capital Employed (ROCE)
-5.70%-5.70%-3.30%-9.20%-3.50%0.70%
Upgrade
Earnings Yield
-15.93%-15.56%7.00%-41.36%-40.11%-9.20%
Upgrade
FCF Yield
-4.89%-5.47%-10.56%-16.17%-18.05%-2.49%
Upgrade
Buyback Yield / Dilution
5.02%5.02%-22.36%-1.67%-0.59%-0.45%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.